Bailard Inc. Buys Shares of 12,300 Pediatrix Medical Group, Inc. (NYSE:MD)

Bailard Inc. purchased a new position in Pediatrix Medical Group, Inc. (NYSE:MD) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 12,300 shares of the company’s stock, valued at approximately $161,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Quest Partners LLC raised its holdings in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after purchasing an additional 622 shares in the last quarter. Parkside Financial Bank & Trust grew its position in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after buying an additional 1,040 shares during the last quarter. Quarry LP raised its stake in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after acquiring an additional 1,662 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in Pediatrix Medical Group by 750.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after acquiring an additional 6,090 shares during the last quarter. Finally, FMR LLC boosted its stake in Pediatrix Medical Group by 220.6% in the third quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after acquiring an additional 6,771 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Trading Up 1.1 %

Shares of NYSE:MD opened at $14.59 on Thursday. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67. The stock has a market cap of $1.25 billion, a price-to-earnings ratio of -12.16, a PEG ratio of 1.74 and a beta of 1.57. The business has a 50-day moving average price of $14.02 and a 200-day moving average price of $13.25.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on MD shares. Mizuho upped their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. UBS Group increased their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Macquarie assumed coverage on Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target for the company. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Finally, Truist Financial lifted their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Pediatrix Medical Group has an average rating of “Hold” and an average target price of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.